J. Kwon

发表

Dose‐independent pharmacokinetics of torasemide after intravenous and oral administration to rats

Ji Young Kim, D. Y. Lee, Yu C. Kim, 2005, Biopharmaceutics & drug disposition.

Pharmacokinetic changes of DA-7867, a new oxazolidinone, after intravenous and oral administration to rats with short-term and long-term diabetes mellitus induced by streptozotocin.

J. Kwon, Won Bae Kim, M. Lee, 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Bioequivalence of clarithromycin tablet formulations assessed in Korean males.

H. J. Kim, J. Kwon, M. Lee, 2001, International journal of clinical pharmacology and therapeutics.

Interspecies pharmacokinetic scaling of DA‐8159, a new erectogenic, in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics

So H. Kim, Yu C. Kim, J. Kwon, 2005, Biopharmaceutics & drug disposition.

Chronic administration of phosphodiesterase 5 inhibitor improves erectile and endothelial function in a rat model of diabetes.

W. Hwang, Byeong-chun Lee, S. Kang, 2005, International journal of andrology.

The effect of DA-8159 on corpus cavernosal smooth muscle relaxation and penile erection in diabetic rabbits

W. Kim, J. Kwon, S. Choi, 2004, Urological Research.

Effects of cysteine on the pharmacokinetics of intravenous chlorzoxazone in rats with protein-calorie malnutrition.

Sang -Geon Kim, M. Cho, C. Shim, 2002, Biopharmaceutics & drug disposition.

Effects of cysteine on the pharmacokinetics of intravenous phenytoin in rats with protein-calorie malnutrition.

M. Cho, C. Shim, J. Kwon, 2001, International journal of pharmaceutics.

DA-9201 shows anti-asthmatic effects by suppressing NF-кB expression in an ovalbumin-lnduced mouse model of asthma

J. Kwon, Seung-Ho Lee, S. Choi, 2005, Archives of pharmacal research.

Microarray analysis of gene expression profile in the corpus cavernosum of hypercholesterolemic rats after chronic treatment with PDE5 inhibitor.

J. Kwon, M. Yoo, K. Kang, 2007, Life sciences.

The effect of PDE5 inhibition on the erectile function in streptozotocin-induced diabetic rats

W. Hwang, J. Kwon, S. K. Kang, 2005, International Journal of Impotence Research.

Pharmacokinetic interaction between 5‐[2‐propyloxy‐5‐(1‐methyl‐2‐pyrollidinylethylamidosulfonyl)phenyl]‐1‐methyl‐3‐propyl‐1,6‐dihydro‐7H‐pyrazolo (4,3‐d) pyrimidine‐7‐one (DA‐8159) and nitroglycerin in rats

Myung G. Lee, J. Kwon, S. Bae, 2005, The Journal of pharmacy and pharmacology.

Effects of water deprivation on the pharmacokinetics of DA-8159, a new erectogenic, in rats.

Ji Young Kim, Myung G. Lee, Yu C. Kim, 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

Effects of cysteine on the pharmacokinetics of oltipraz in rats with protein-calorie malnutrition.

J. Kwon, M. Lee, S. Bae, 2005, Journal of pharmaceutical sciences.

Effects of cysteine on the pharmacokinetics of intravenous torasemide in rats with protein-calorie malnutrition.

Sang -Geon Kim, C. Shim, Myung G. Lee, 2004, Journal of pharmaceutical sciences.

Pharmacokinetic changes of DA-8159, a new erectogenic, after intravenous and oral administration to rats with diabetes mellitus induced by streptozotocin.

Yu C. Kim, J. Kwon, Won Bae Kim, 2004, Journal of pharmaceutical sciences.

Effects of glucose on the pharmacokinetics of intravenous chlorzoxazone in rats with acute renal failure induced by uranyl nitrate.

E. J. Kim, Sang -Geon Kim, J. Kwon, 2003, Journal of pharmaceutical sciences.

Inhibitory effect of DA-9201, an extract of Oryza sativa L., on airway inflammation and bronchial hyperresponsiveness in mouse asthma model.

J. Kwon, Seung-Ho Lee, M. Yoo, 2006, Biological & pharmaceutical bulletin.

Pharmacokinetics of 7‐carboxymethyloxy‐3‘,4’,5‐trimethoxy flavone (DA‐6034), a derivative of flavonoid, in mouse and rat models of chemically‐induced inflammatory bowel disease

E. J. Kim, Myung G. Lee, J. Kwon, 2006, The Journal of pharmacy and pharmacology.

Determination of a new phosphodiesterase V inhibitor, DA-8159, in plasma and urine by high-performance liquid chromatography.

So H. Kim, Myung G. Lee, J. Kwon, 2002, Journal of pharmaceutical and biomedical analysis.

Pharmacokinetic and pharmacodynamic consequences of inhibition of terazosin metabolism via CYP3A1 and/or 3A2 by DA‐8159, an erectogenic, in rats

J. Kwon, M. Lee, D. C. Lee, 2007, British journal of pharmacology.

Negligible pharmacokinetic interaction between oral DA‐8159, a new erectogenic, and amlodipine in rats

E. J. Kim, Myung G. Lee, J. Kwon, 2006, Biopharmaceutics & drug disposition.

Effects of omeprazole or cola beverage on the pharmacokinetics of oral DA-8159, a new erectogenic, in rats.

J. Kwon, Won Bae Kim, M. Lee, 2005, Biopharmaceutics & drug disposition.

Pharmacokinetic changes of DA‐8159, a new erectogenic, and one of its metabolites, DA‐8164 after intravenous and oral administration of DA‐8159 to spontaneously hypertensive rats and DOCA–salt‐induced hypertensive rats

Yu C. Kim, J. Kwon, Won Bae Kim, 2005, Biopharmaceutics & drug disposition.

Effects of enzyme inducers and inhibitors on the pharmacokinetics of intravenous DA‐8159, a new erectogenic, in rats

Yu C. Kim, J. Kwon, Won Bae Kim, 2005, Biopharmaceutics & drug disposition.

Pharmacokinetics of DA-8159, a new erectogenic, administered at 10:00 h versus 22:00 h in rats.

Yu C. Kim, J. Kwon, Won Bae Kim, 2005, International journal of pharmaceutics.

Pharmacokinetics of intravenous and oral DA‐8159, a new erectogenic, in rats with protein‐calorie malnutrition

Myung G. Lee, Yu C. Kim, J. Kwon, 2004, The Journal of pharmacy and pharmacology.

Subacute toxicities and toxicokinetics of DA‐8159, a new phosphodiesterase type V inhibitor, after single and 4‐Week repeated oral administration in rats

Myung G. Lee, Yu C. Kim, J. Kwon, 2003, Biopharmaceutics & drug disposition.

Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: hepatic and intestinal first-pass effects.

Yu C. Kim, J. Kwon, Won Bae Kim, 2003, Journal of pharmaceutical sciences.

Penile erectile responses to electric stimulation are enhanced by a new phosphodiesterase type‐5 inhibitor

J. Kwon, M. Yoo, K. Kang, 2005, International journal of urology : official journal of the Japanese Urological Association.

Subacute toxicities and toxicokinetics of a new erectogenic, DA-8159, after single and 4-week repeated oral administration in dogs.

J. Kim, J. Kwon, S. Cha, 2001, Biopharmaceutics & drug disposition.

Factors influencing the protein binding of a new phosphodiesterase V inhibitor, DA-8159, using an equilibrium dialysis technique.

J. Kwon, H. Shim, M. Lee, 2000, Biopharmaceutics & drug disposition.

Pharmacokinetics, stability, and blood partition of DA-8159, a new phosphodiesterase V inhibitor.

H. S. Lee, J. Kwon, H. Shim, 2000, Research communications in molecular pathology and pharmacology.

The effect of DA-8159, a novel PDE5 inhibitor, on erectile function in the rat model of hypercholesterolemic erectile dysfunction

J. Kwon, J. Y. Yu, M. Yoo, 2005, International Journal of Impotence Research.

Species differences in the formation of DA-8164 after intravenous and/or oral administration of DA-8159, a new erectogenic, to mice, rats, rabbits, dogs and humans.

Yu C. Kim, J. Kwon, Won Bae Kim, 2005, Biopharmaceutics & drug disposition.

Effects of protein‐calorie malnutrition on the pharmacokinetics of DA‐7867, a new oxazolidinone, in rats

Myung G. Lee, J. Kwon, Won Bae Kim, 2004, The Journal of pharmacy and pharmacology.

Effects of cysteine on the pharmacokinetics of intravenous 2-(allylthio)pyrazine, a new chemoprotective agent, in rats with protein-calorie malnutrition.

Sang -Geon Kim, M. Cho, Myung G. Lee, 2003, International journal of pharmaceutics.

Excretion and metabolism of DA-7867, a new oxazolidinone, in rats.

E. J. Kim, J. Kwon, Won Bae Kim, 2005, Biopharmaceutics & drug disposition.

Effects of cysteine on the pharmacokinetics of intravenous clarithromycin in rats with protein-calorie malnutrition.

E. J. Kim, Sang -Geon Kim, C. Shim, 2003, Life sciences.

Effects of water deprivation for 72 hours on the pharmacokinetics of a new carbapenem, DA-1131, in rats.

So H. Kim, Myung G. Lee, J. Kwon, 2002, Life sciences.

Effects of Cilastatin on the Pharmacokinetics of a New Carbapenem, DA-1131, in Rats, Rabbits, and Dogs

So H. Kim, Myung G. Lee, J. Kwon, 1999, Antimicrobial Agents and Chemotherapy.

Nephroprotective effect of betamipron on a new carbapenem, DA‐1131, in rabbits

J. Kwon, M. Lee, S. H. Kim, 1999, Biopharmaceutics & drug disposition.

Pharmacokinetics and tissue distribution of a new carbapenem, DA‐1131, after intravenous administration to mice, rats, rabbits and dogs

So H. Kim, J. Kwon, M. Lee, 1998, Biopharmaceutics & drug disposition.

Determination of a new carbapenem derivative, DA-1131, in plasma and urine by high-performance liquid chromatography.

J. Yang, J. Kwon, M. Lee, 1997, Journal of chromatography. B, Biomedical sciences and applications.

Pharmacokinetics of DA-6034, an agent for inflammatory bowel disease, in rats and dogs: Contribution of intestinal first-pass effect to low bioavailability in rats.

Myung G. Lee, J. Kwon, Hye J. Chung, 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

Gender differences in the pharmacokinetics of DA-6034, a derivative of flavonoids, in rats.

J. Kwon, M. Lee, S. Bae, 2006, Biopharmaceutics & drug disposition.

Effects of cysteine on the pharmacokinetics of itraconazole in rats with protein‐calorie malnutrition

E. J. Kim, Sang -Geon Kim, C. Shim, 2003, Biopharmaceutics & drug disposition.

Pharmacokinetics of clarithromycin in rats with acute renal failure induced by uranyl nitrate

Sang -Geon Kim, So H. Kim, J. Kwon, 2004, Biopharmaceutics & drug disposition.

Effects of cysteine on amino acid concentrations and transsulfuration enzyme activities in rat liver with protein-calorie malnutrition.

O. Park, Myung G. Lee, J. Kwon, 2003, Life sciences.

Pharmacokinetics of DA-7867, a New Oxazolidinone, after Intravenous or Oral Administration to Rats: Intestinal First-Pass Effect

E. J. Kim, Myung G. Lee, J. Kwon, 2004, Antimicrobial Agents and Chemotherapy.

Comparative bioavailability of silibinin in healthy male volunteers.

E. D. Lee, J. Kwon, Y. G. Kim, 2003, International journal of clinical pharmacology and therapeutics.